Infusion toxicology studies help to determine the effective and safe concentration of drug in systemic circulation, which can produce the desired pharmacological action with minimum adverse effects.听
The global market for Infusion Toxicology Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Infusion Toxicology Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Infusion Toxicology Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Infusion Toxicology Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Infusion Toxicology Services include Creative Animodel, Smithers Avanza, Envigo, Creative Biolabs, Charles River, Covance, Citoxlab, MPI Research and IITRI, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Infusion Toxicology Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infusion Toxicology Services by region & country, by Type, and by Application.
The Infusion Toxicology Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infusion Toxicology Services.
麻豆原创 Segmentation
By Company
Creative Animodel
Smithers Avanza
Envigo
Creative Biolabs
Charles River
Covance
Citoxlab
MPI Research
IITRI
Segment by Type:
Infusion Pumps
Consumables
Analytical Instruments
Others
Segment by Application
Oncology
Infectious diseases
Central Nervous System
Inflammatory/Auto-Immune Diseases
Cardiac Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Infusion Toxicology Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Infusion Toxicology Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Infusion Toxicology Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Infusion Toxicology Services Product Introduction
1.2 Global Infusion Toxicology Services 麻豆原创 Size Forecast
1.3 Infusion Toxicology Services 麻豆原创 Trends & Drivers
1.3.1 Infusion Toxicology Services Industry Trends
1.3.2 Infusion Toxicology Services 麻豆原创 Drivers & Opportunity
1.3.3 Infusion Toxicology Services 麻豆原创 Challenges
1.3.4 Infusion Toxicology Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Infusion Toxicology Services Players Revenue Ranking (2023)
2.2 Global Infusion Toxicology Services Revenue by Company (2019-2024)
2.3 Key Companies Infusion Toxicology Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Infusion Toxicology Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Infusion Toxicology Services
2.6 Infusion Toxicology Services 麻豆原创 Competitive Analysis
2.6.1 Infusion Toxicology Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Infusion Toxicology Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infusion Toxicology Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Infusion Pumps
3.1.2 Consumables
3.1.3 Analytical Instruments
3.1.4 Others
3.2 Global Infusion Toxicology Services Sales Value by Type
3.2.1 Global Infusion Toxicology Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Infusion Toxicology Services Sales Value, by Type (2019-2030)
3.2.3 Global Infusion Toxicology Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology
4.1.2 Infectious diseases
4.1.3 Central Nervous System
4.1.4 Inflammatory/Auto-Immune Diseases
4.1.5 Cardiac Diseases
4.1.6 Others
4.2 Global Infusion Toxicology Services Sales Value by Application
4.2.1 Global Infusion Toxicology Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Infusion Toxicology Services Sales Value, by Application (2019-2030)
4.2.3 Global Infusion Toxicology Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Infusion Toxicology Services Sales Value by Region
5.1.1 Global Infusion Toxicology Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Infusion Toxicology Services Sales Value by Region (2019-2024)
5.1.3 Global Infusion Toxicology Services Sales Value by Region (2025-2030)
5.1.4 Global Infusion Toxicology Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Infusion Toxicology Services Sales Value, 2019-2030
5.2.2 North America Infusion Toxicology Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Infusion Toxicology Services Sales Value, 2019-2030
5.3.2 Europe Infusion Toxicology Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Infusion Toxicology Services Sales Value, 2019-2030
5.4.2 Asia Pacific Infusion Toxicology Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Infusion Toxicology Services Sales Value, 2019-2030
5.5.2 South America Infusion Toxicology Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Infusion Toxicology Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Infusion Toxicology Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Infusion Toxicology Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Infusion Toxicology Services Sales Value
6.3 United States
6.3.1 United States Infusion Toxicology Services Sales Value, 2019-2030
6.3.2 United States Infusion Toxicology Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Infusion Toxicology Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Infusion Toxicology Services Sales Value, 2019-2030
6.4.2 Europe Infusion Toxicology Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Infusion Toxicology Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Infusion Toxicology Services Sales Value, 2019-2030
6.5.2 China Infusion Toxicology Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Infusion Toxicology Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Infusion Toxicology Services Sales Value, 2019-2030
6.6.2 Japan Infusion Toxicology Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Infusion Toxicology Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Infusion Toxicology Services Sales Value, 2019-2030
6.7.2 South Korea Infusion Toxicology Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Infusion Toxicology Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Infusion Toxicology Services Sales Value, 2019-2030
6.8.2 Southeast Asia Infusion Toxicology Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Infusion Toxicology Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Infusion Toxicology Services Sales Value, 2019-2030
6.9.2 India Infusion Toxicology Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Infusion Toxicology Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Creative Animodel
7.1.1 Creative Animodel Profile
7.1.2 Creative Animodel Main Business
7.1.3 Creative Animodel Infusion Toxicology Services Products, Services and Solutions
7.1.4 Creative Animodel Infusion Toxicology Services Revenue (US$ Million) & (2019-2024)
7.1.5 Creative Animodel Recent Developments
7.2 Smithers Avanza
7.2.1 Smithers Avanza Profile
7.2.2 Smithers Avanza Main Business
7.2.3 Smithers Avanza Infusion Toxicology Services Products, Services and Solutions
7.2.4 Smithers Avanza Infusion Toxicology Services Revenue (US$ Million) & (2019-2024)
7.2.5 Smithers Avanza Recent Developments
7.3 Envigo
7.3.1 Envigo Profile
7.3.2 Envigo Main Business
7.3.3 Envigo Infusion Toxicology Services Products, Services and Solutions
7.3.4 Envigo Infusion Toxicology Services Revenue (US$ Million) & (2019-2024)
7.3.5 Creative Biolabs Recent Developments
7.4 Creative Biolabs
7.4.1 Creative Biolabs Profile
7.4.2 Creative Biolabs Main Business
7.4.3 Creative Biolabs Infusion Toxicology Services Products, Services and Solutions
7.4.4 Creative Biolabs Infusion Toxicology Services Revenue (US$ Million) & (2019-2024)
7.4.5 Creative Biolabs Recent Developments
7.5 Charles River
7.5.1 Charles River Profile
7.5.2 Charles River Main Business
7.5.3 Charles River Infusion Toxicology Services Products, Services and Solutions
7.5.4 Charles River Infusion Toxicology Services Revenue (US$ Million) & (2019-2024)
7.5.5 Charles River Recent Developments
7.6 Covance
7.6.1 Covance Profile
7.6.2 Covance Main Business
7.6.3 Covance Infusion Toxicology Services Products, Services and Solutions
7.6.4 Covance Infusion Toxicology Services Revenue (US$ Million) & (2019-2024)
7.6.5 Covance Recent Developments
7.7 Citoxlab
7.7.1 Citoxlab Profile
7.7.2 Citoxlab Main Business
7.7.3 Citoxlab Infusion Toxicology Services Products, Services and Solutions
7.7.4 Citoxlab Infusion Toxicology Services Revenue (US$ Million) & (2019-2024)
7.7.5 Citoxlab Recent Developments
7.8 MPI Research
7.8.1 MPI Research Profile
7.8.2 MPI Research Main Business
7.8.3 MPI Research Infusion Toxicology Services Products, Services and Solutions
7.8.4 MPI Research Infusion Toxicology Services Revenue (US$ Million) & (2019-2024)
7.8.5 MPI Research Recent Developments
7.9 IITRI
7.9.1 IITRI Profile
7.9.2 IITRI Main Business
7.9.3 IITRI Infusion Toxicology Services Products, Services and Solutions
7.9.4 IITRI Infusion Toxicology Services Revenue (US$ Million) & (2019-2024)
7.9.5 IITRI Recent Developments
8 Industry Chain Analysis
8.1 Infusion Toxicology Services Industrial Chain
8.2 Infusion Toxicology Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Infusion Toxicology Services Sales Model
8.5.2 Sales Channel
8.5.3 Infusion Toxicology Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Creative Animodel
Smithers Avanza
Envigo
Creative Biolabs
Charles River
Covance
Citoxlab
MPI Research
IITRI
听
听
*If Applicable.